Screener
Eligibility screening
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
4 US sites in AR, NC, NV
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.